EUVIMEDOpdag EUVIMED
Crossref

Catheter‐based therapy for intermediate or high‐risk pulmonary embolism is associated with lower in‐hospital mortality in patients with cancer: Insights from the National Inpatient Sample

Orly Leiva iD, Eugene Yuriditsky, Radu Postelnicu, Eric H Yang iD, Vikramjit Mukherjee, Allison Greco, James Horowitz, Carlos Alviar, Sripal Bangalore iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.30917 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2024. Written by Orly Leiva and 8 co-authors. Institution: Department of Medicine, Division of Cardiology, New York University Grossman School of Medicine, New York, New York, USA. Major MEDLINE topics: Pulmonary Embolism, Neoplasms. Cited 8 times so far (Crossref); 26 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Pulmonary embolism (PE) is a common complication among patients with cancer and is a significant contributor to morbidity and mortality. Catheter‐based therapies (CBT), including catheter‐directed thrombolysis (CDT) and mechanical thrombectomy, have been developed and are used in patients with intermediate or high‐risk PE. However, there is a paucity of data on outcomes in patients with cancer as most clinical studies exclude this group of patients.

Aims

To characterize outcomes of patients with cancer admitted with intermediate or high‐risk PE treated with CBT compared with no CBT.

Methods

Patients with an admission diagnosis of intermediate or high‐risk PE and a history of cancer from October 2015 to December 2018 were identified using the National Inpatient Sample. Outcomes of interest were in‐hospital death or cardiac arrest (CA) and major bleeding. Inverse probability treatment weighting (IPTW) was utilized to compare outcomes between patients treated with and without CBT. Variables that remained unbalanced after IPTW were adjusted using multivariable logistic regression.

Results

A total of 2084 unweighted admissions (10,420 weighted) for intermediate or high‐risk PE and cancer were included, of which 136 (6.5%) were treated with CBT. After IPTW, CBT was associated with lower death or CA (aOR 0.54, 95% CI 0.46–0.64) but higher major bleeding (aOR 1.41, 95% CI 1.21–1.65). After stratifying by PE risk type, patients treated with CBT had lower risk of death or CA in both intermediate (aOR 0.52, 95% CI 0.36–0.75) and high‐risk PE (aOR 0.48, 95% CI 0.33–0.53). However, patients with CBT were associated with increased risk of major bleeding in intermediate‐risk PE (aOR 2.12, 95% CI 1.67–2.69) but not in those with high‐risk PE (aOR 0.84, 95% CI 0.66–1.07).

Conclusions

Among patients with cancer hospitalized with intermediate or high‐risk PE, treatment with CBT was associated with lower risk of in‐hospital death or CA but higher risk of bleeding. Prospective studies and inclusion of patients with cancer in randomized trials are warranted to confirm our findings.

Subjects

MeSH terms (MEDLINE)

Pulmonary EmbolismNeoplasmsHumansThrombolytic TherapyHospital MortalityFibrinolytic AgentsInpatientsProspective StudiesTreatment OutcomeCathetersHemorrhageRetrospective Studies

Author keywords

cancer-associated VTEcatheter-based therapycatheter-directed thrombolysismechanical thrombectomypulmonary embolism

Substances

Fibrinolytic Agents

Authors and institutions

  • Department of Medicine, Division of Cardiology, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Medicine, Division of Pulmonology and Critical Care, New York University Grossman School of Medicine, New York, New York, USA.
  • Department of Medicine, Division of Cardiology, UCLA Cardio-Oncology Program, University of California Los Angeles, Los Angeles, California, USA.

ORCID profiles: Orly Leiva, Eric H Yang, Sripal Bangalore

Cite

APA

Leiva, O., Yuriditsky, E., Postelnicu, R., Yang, E. H., Mukherjee, V., Greco, A., Horowitz, J., Alviar, C., & Bangalore, S. (2024). Catheter‐based therapy for intermediate or high‐risk pulmonary embolism is associated with lower in‐hospital mortality in patients with cancer: Insights from the National Inpatient Sample. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30917

Vancouver

Leiva O, Yuriditsky E, Postelnicu R, Yang EH, Mukherjee V, Greco A, et al. Catheter‐based therapy for intermediate or high‐risk pulmonary embolism is associated with lower in‐hospital mortality in patients with cancer: Insights from the National Inpatient Sample. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30917

BibTeX
@article{Leiva2024,
  author = {Leiva, Orly and Yuriditsky, Eugene and Postelnicu, Radu and Yang, Eric H and Mukherjee, Vikramjit and Greco, Allison and Horowitz, James and Alviar, Carlos and Bangalore, Sripal},
  title = {Catheter‐based therapy for intermediate or high‐risk pulmonary embolism is associated with lower in‐hospital mortality in patients with cancer: Insights from the National Inpatient Sample},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.30917}
}
Start for free →